Price $13.44 |
Market Cap
27.1M
|
Sector Health Care |
Div. Growth
-59.80%
|
|
P/E
11.9
|
P/B
2.54
|
P/S
2.56
|
Dividend %
7.10%
|
|
P/CF
4.3
|
P/FCF
36.8
|
Op. Cash Flow
2.2K
|
FCF
0.1
|
|
Op. Margin
26.80%
|
Net Margin
21.60%
|
ROE
22.50%
|
ROI
36.30%
|
|
ROA
19.40%
|
EPS Growth
-39.00%
|
Current Ratio
7.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
